Sartorius Stedim Biotech SA DIM
EURONEXT · France · Health Technology
€206.20-6.60 (-3.10%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-23 | 1.25 | 1.26 | -1.0% | €765.70M | -3.5% | -4.6%€175.30→€167.30 |
| Q4 2025 | 2026-02-03 | 1.12 | 1.30 | -13.8% | — | — | -3.3%€187.25→€181.00 |
| Q3 2025 | 2025-10-16 | 0.94 | 1.01 | -6.9% | — | — | +9.0%€185.95→€202.60 |
| Q2 2025 | 2025-07-22 | 1.18 | 1.05 | +12.4% | — | — | — |
| Q1 2025 | 2025-04-16 | 1.16 | 0.94 | +23.4% | — | — | — |
| Q4 2024 | 2025-01-28 | 1.03 | 1.02 | +1.0% | — | — | — |
| Q3 2024 | 2024-10-17 | 0.76 | 0.84 | -9.5% | — | — | — |
| Q2 2024 | 2024-07-18 | 0.85 | 1.02 | -16.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.